Charlottesville Medical Research Center

Charlottesville, Virginia 22911-3589

0 studies enrolling now · 11 studies all time

What they study most

Central Abdominal Bulging, Chronic Idiopathic Constipation, Crohn Disease, Epstein-Barr Virus Infection, Gastroesophageal Reflux, Obesity, Overweight, Pneumococcal Vaccines, Type 2 Diabetes, Type 2 Diabetes Mellitus (T2DM)

Studies at this site

• Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD — Completed
• A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Age — Running, not enrolling
• A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults — Running, not enrolling
• A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Running, not enrolling
• Safety and Efficacy Study of S-309309 in Obese Adults — Completed
• Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus — Completed
• THE ENLIGHTEN STUDY — Completed
• Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
• A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease — Withdrawn before enrolling
• Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects — Completed
• Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation — Completed